skip to Main Content

ABOUT           BLOG

ABOUT

Manzo Pharmaceuticals, Inc. (OTC: MNZO)

Robert Ritch has always respected and studied Warren Buffets techniques and planned to implement them in his version and therefore has purchased the controlling block of preferred shares of Manzo Pharmaceuticals, Inc. (OTC: MNZO) and taken the position of President with the firm. Robert Ritch stated the first steps would be to bring the companies filing up to date and then acquire in whole or in part operating companies. There will also be a name change, but the new name has not been finalized or filed for at this time. The currently planned verticals are energy, technology, real estate and financial services.

Questions & Comments About MNZO

BLOG

Recent Posts

MNZO August 11 2017 report with President Robert Ritch

Robert Ritch Manzo Pharmaceuticals, Inc. 615-241-5241 rob@robertritch.com MNZO Weekly Update August 11, 2017 President Robert Ritch provides…

Read More

MNZO August 4 2017 by President Robert Ritch

It has been a busy but productive week; here are the highlights: The previous management…

Read More

New Acquisition Target 50 year Old Furniture Manufacturer

I had a great meeting yesterday with a 50-year-old furniture manufacturer; we are negotiating the letter…

Read More

Manzo Management Services Update

We signed off on the logo today that was prepared by Simple Marketing Inc. and…

Read More